Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forbes

Showing results (191-200 of 309) with videos related to

Pageof 31
Sort By:
The Medical Journal of Australia|October 6, 1986
Psychological treatment of phobic anxiety associated with adjuvant chemotherapyD J Horne, H M McCormack, J P Collins, et al.
Journal of the National Cancer Institute|February 22, 2007
Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trialJack Cuzick, John F Forbes, Ivana Sestak, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluationC M Lambert, N P Hurst, J F Forbes, et al.
British Journal of Cancer|June 28, 2012
Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trialI Sestak, R Kealy, M Nikoloff, et al.
Plos One|June 16, 2011
Risk-targeted selection of agricultural holdings for post-epidemic surveillance: estimation of efficiency gainsIan G Handel, Barend M de C Bronsvoort, John F Forbes, et al.
Plos One|April 26, 2019
Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research CentresJoel B E Smith, Keith M Channon, Vasiliki Kiparoglou, et al.
The Lancet. Oncology|November 20, 2010
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trialJack Cuzick, Ivana Sestak, Michael Baum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials GroupA Coates, V Gebski, D Signorini, et al.
BMC Cancer|February 1, 2014
Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancerKelly A Avery-Kiejda, Stephen G Braye, Andrea Mathe, et al.
The Medical Journal of Australia|January 20, 1992
Promotion of attendance for mammographic screening through general practice: a randomised trial of two strategiesK A Clover, S Redman, J F Forbes, et al.
Pageof 31

Showing results (191-200 of 309) with videos related to

Sort By:
Pageof 31
The Medical Journal of Australia|October 6, 1986
Psychological treatment of phobic anxiety associated with adjuvant chemotherapyD J Horne, H M McCormack, J P Collins, et al.
Journal of the National Cancer Institute|February 22, 2007
Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trialJack Cuzick, John F Forbes, Ivana Sestak, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluationC M Lambert, N P Hurst, J F Forbes, et al.
British Journal of Cancer|June 28, 2012
Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trialI Sestak, R Kealy, M Nikoloff, et al.
Plos One|June 16, 2011
Risk-targeted selection of agricultural holdings for post-epidemic surveillance: estimation of efficiency gainsIan G Handel, Barend M de C Bronsvoort, John F Forbes, et al.
Plos One|April 26, 2019
Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research CentresJoel B E Smith, Keith M Channon, Vasiliki Kiparoglou, et al.
The Lancet. Oncology|November 20, 2010
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trialJack Cuzick, Ivana Sestak, Michael Baum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials GroupA Coates, V Gebski, D Signorini, et al.
BMC Cancer|February 1, 2014
Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancerKelly A Avery-Kiejda, Stephen G Braye, Andrea Mathe, et al.
The Medical Journal of Australia|January 20, 1992
Promotion of attendance for mammographic screening through general practice: a randomised trial of two strategiesK A Clover, S Redman, J F Forbes, et al.
Pageof 31